Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00415272 · ClinicalTrials.gov registry record · NA
Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
NCT00415272 is a NA study that was terminated before completion, run by University of California, San Francisco.
The verdict
NCT00415272, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
Our study aims to investigate the benefits of an outpatient pulmonary rehabilitation program in a population of subjects with fibrotic interstitial lung disease. Our hypothesis is that pulmonary rehabilitation will lead to improvements in quality of life, breathlessness, exercise capacity and pulmonary function in this patient population.
Interventions
- BEHAVIORAL Pulmonary Rehabilitation
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00415272
The ClinicalTrials.gov registry entry for NCT00415272 describes a study currently listed as terminated, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulmonary Rehabilitation is the first listed.
NCT00415272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00415272 about?
NCT00415272 is a clinical study titled "Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease". Our study aims to investigate the benefits of an outpatient pulmonary rehabilitation program in a population of subjects with fibrotic interstitial lung disease. Our hypothesis is that pulmonary rehabilitation will lead to improvements in quality of life, breathlessness, exercise capacity and pulmon...
What is the current status of trial NCT00415272?
This trial is currently terminated. It is a NA study. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00415272?
The interventions under investigation include: Pulmonary Rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00415272?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.